Cura Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Buy
602
+32
+6% +$32.7K 0.31% 49
2026
Q1
$524K Sell
570
-297
-34% -$301K 0.23% 59
2025
Q4
$932K Buy
867
+296
+52% +$283K 0.35% 40
2025
Q3
$436K Buy
571
+149
+35% +$111K 0.17% 63
2025
Q2
$329K Buy
422
+47
+13% +$36.5K 0.13% 71
2025
Q1
$310K Buy
+375
New +$312K 0.13% 73

Other funds holding LLY

Cura Wealth Advisors's LLY Position: Q2 2026 in Review

Cura Wealth Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $32.7K and bringing the position to 602 shares worth $722K. The position accounts for 0.31% of the portfolio, ranked #49.

Cura Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. The position peaked at $932K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cura Wealth Advisors held 602 shares of Eli Lilly worth $722K as of Q2 2026.
  • Cura Wealth Advisors bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 0.31% of Cura Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • Cura Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • Cura Wealth Advisors's Eli Lilly position peaked at $932K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cura Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.